1. Home
  2. SSBI vs MXCT Comparison

SSBI vs MXCT Comparison

Compare SSBI & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SSBI

Summit State Bank

HOLD

Current Price

$13.50

Market Cap

91.6M

Sector

Finance

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.02

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSBI
MXCT
Founded
1982
1999
Country
United States
United States
Employees
103
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.6M
93.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SSBI
MXCT
Price
$13.50
$1.02
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
3.9K
562.2K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
$13.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.20
$0.64
52 Week High
$14.00
$2.40

Technical Indicators

Market Signals
Indicator
SSBI
MXCT
Relative Strength Index (RSI) 47.48 69.63
Support Level $12.78 $0.77
Resistance Level $13.58 $1.81
Average True Range (ATR) 0.15 0.07
MACD -0.02 0.01
Stochastic Oscillator 65.49 65.43

Price Performance

Historical Comparison
SSBI
MXCT

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: